Vijay Kumar
Stock Analyst at Evercore ISI Group
(2.24)
# 2,537
Out of 4,826 analysts
203
Total ratings
40.68%
Success rate
-4.77%
Average return
Main Sectors:
Stocks Rated by Vijay Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYK Stryker | Maintains: Outperform | $400 → $390 | $381.56 | +2.21% | 10 | May 2, 2025 | |
| HOLX Hologic | Maintains: In-Line | $65 → $62 | $52.72 | +17.60% | 14 | May 2, 2025 | |
| EXAS Exact Sciences | Maintains: Outperform | $60 → $66 | $53.32 | +23.78% | 4 | May 2, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Outperform | $96 → $85 | $69.37 | +22.53% | 4 | May 1, 2025 | |
| BLCO Bausch + Lomb | Maintains: Outperform | $19 → $16 | $11.33 | +36.80% | 8 | May 1, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $585 → $500 | $422.62 | +18.31% | 11 | Apr 24, 2025 | |
| BSX Boston Scientific | Maintains: Outperform | $110 → $112 | $104.18 | +7.51% | 6 | Apr 24, 2025 | |
| ISRG Intuitive Surgical | Maintains: In-Line | $510 → $470 | $531.82 | -11.62% | 12 | Apr 23, 2025 | |
| EW Edwards Lifesciences | Maintains: In-Line | $75 → $73 | $75.20 | -2.93% | 11 | Feb 12, 2025 | |
| MTD Mettler-Toledo International | Maintains: Outperform | $1,450 → $1,475 | $1,090.55 | +35.25% | 9 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $50 → $52 | $26.18 | +98.62% | 6 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $207 → $202 | $133.59 | +51.21% | 6 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $18 → $30 | $17.77 | +68.82% | 11 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $145 → $142 | $108.53 | +30.84% | 3 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $51 → $54 | $41.48 | +30.18% | 4 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $113 → $110 | $90.48 | +21.57% | 12 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $335 → $355 | $348.13 | +1.97% | 8 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $52 → $56 | $35.98 | +55.64% | 5 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $160 | $119.06 | +34.39% | 7 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $104 | $83.35 | +24.78% | 4 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $62 → $58 | $34.17 | +69.74% | 3 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $275 → $278 | $197.41 | +40.82% | 2 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $286 → $290 | $166.85 | +73.81% | 6 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $124 | $132.64 | -6.51% | 10 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $4.5 → $5 | $2.85 | +75.44% | 3 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $46 → $45 | $30.47 | +47.69% | 6 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $28 → $27 | $12.64 | +113.61% | 10 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $195 → $175 | $78.21 | +123.76% | 6 | Jun 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $88 → $125 | $92.89 | +34.57% | 1 | Jan 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $0.68 | +937.04% | 1 | May 31, 2022 |
Stryker
May 2, 2025
Maintains: Outperform
Price Target: $400 → $390
Current: $381.56
Upside: +2.21%
Hologic
May 2, 2025
Maintains: In-Line
Price Target: $65 → $62
Current: $52.72
Upside: +17.60%
Exact Sciences
May 2, 2025
Maintains: Outperform
Price Target: $60 → $66
Current: $53.32
Upside: +23.78%
GE HealthCare Technologies
May 1, 2025
Maintains: Outperform
Price Target: $96 → $85
Current: $69.37
Upside: +22.53%
Bausch + Lomb
May 1, 2025
Maintains: Outperform
Price Target: $19 → $16
Current: $11.33
Upside: +36.80%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Outperform
Price Target: $585 → $500
Current: $422.62
Upside: +18.31%
Boston Scientific
Apr 24, 2025
Maintains: Outperform
Price Target: $110 → $112
Current: $104.18
Upside: +7.51%
Intuitive Surgical
Apr 23, 2025
Maintains: In-Line
Price Target: $510 → $470
Current: $531.82
Upside: -11.62%
Edwards Lifesciences
Feb 12, 2025
Maintains: In-Line
Price Target: $75 → $73
Current: $75.20
Upside: -2.93%
Mettler-Toledo International
Feb 10, 2025
Maintains: Outperform
Price Target: $1,450 → $1,475
Current: $1,090.55
Upside: +35.25%
Feb 6, 2025
Maintains: In-Line
Price Target: $50 → $52
Current: $26.18
Upside: +98.62%
Jan 17, 2025
Maintains: Outperform
Price Target: $207 → $202
Current: $133.59
Upside: +51.21%
Dec 2, 2024
Upgrades: Outperform
Price Target: $18 → $30
Current: $17.77
Upside: +68.82%
Nov 26, 2024
Maintains: In-Line
Price Target: $145 → $142
Current: $108.53
Upside: +30.84%
Oct 30, 2024
Maintains: In-Line
Price Target: $51 → $54
Current: $41.48
Upside: +30.18%
Oct 1, 2024
Maintains: In-Line
Price Target: $113 → $110
Current: $90.48
Upside: +21.57%
Oct 1, 2024
Maintains: In-Line
Price Target: $335 → $355
Current: $348.13
Upside: +1.97%
Oct 1, 2024
Maintains: Outperform
Price Target: $52 → $56
Current: $35.98
Upside: +55.64%
Oct 1, 2024
Maintains: Outperform
Price Target: $120 → $160
Current: $119.06
Upside: +34.39%
Oct 1, 2024
Maintains: Outperform
Price Target: $100 → $104
Current: $83.35
Upside: +24.78%
Oct 1, 2024
Maintains: Outperform
Price Target: $62 → $58
Current: $34.17
Upside: +69.74%
Oct 1, 2024
Maintains: Outperform
Price Target: $275 → $278
Current: $197.41
Upside: +40.82%
Oct 1, 2024
Maintains: Outperform
Price Target: $286 → $290
Current: $166.85
Upside: +73.81%
Oct 1, 2024
Maintains: Outperform
Price Target: $120 → $124
Current: $132.64
Upside: -6.51%
Aug 7, 2024
Maintains: In-Line
Price Target: $4.5 → $5
Current: $2.85
Upside: +75.44%
Jul 2, 2024
Maintains: Outperform
Price Target: $46 → $45
Current: $30.47
Upside: +47.69%
Jul 2, 2024
Maintains: Outperform
Price Target: $28 → $27
Current: $12.64
Upside: +113.61%
Jun 11, 2024
Maintains: Outperform
Price Target: $195 → $175
Current: $78.21
Upside: +123.76%
Jan 4, 2024
Upgrades: Outperform
Price Target: $88 → $125
Current: $92.89
Upside: +34.57%
May 31, 2022
Initiates: Outperform
Price Target: $7
Current: $0.68
Upside: +937.04%